Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells

  • Authors:
    • Kimihiro Yano
    • Mano Horinaka
    • Tatsushi Yoshida
    • Takashi Yasuda
    • Hiroya Taniguchi
    • Ahmed E. Goda
    • Miki Wakada
    • Sae Yoshikawa
    • Terukazu Nakamura
    • Akihiro Kawauchi
    • Tsuneharu Miki
    • Toshiyuki Sakai
  • View Affiliations

  • Published online on: December 15, 2010     https://doi.org/10.3892/ijo.2010.874
  • Pages:365-374
Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is one of the most promising anti-cancer agents, but some tumor types develop resistance to TRAIL. Here, we report that chetomin, an inhibitor of hypoxia-inducible factors, is a potent enhancer of TRAIL-induced apoptosis. TRAIL or chetomin alone weakly induced apoptosis, but the combination of chetomin and TRAIL synergistically induced apoptosis in prostate cancer PC-3 cells. The combination of chetomin and TRAIL induces the activation of caspase-3, -8, -9 and -10. Among the apoptotic factors related to the TRAIL pathway, chetomin markedly decreased the X-linked inhibitor of apoptosis (XIAP) protein levels in a dose-dependent manner, but other IAP family members, TRAIL receptors and Bcl-2 family members were not altered by chetomin. Using XIAP siRNA instead of chetomin, down-regulation of XIAP sensitized PC-3 cells to TRAIL-induced apoptosis. Conversely, transient transfection of XIAP reduced the apoptotic response to combined treatment with chetomin and TRAIL. Treatment with chetomin induced a rapid decrease in XIAP protein levels but had no effect on XIAP mRNA levels. Since chetomin-mediated XIAP down-regulation was completely prevented by proteasome inhibitors, it was suggested that chetomin induces the degradation of the XIAP protein in a proteasome-dependent manner. Additionally, chetomin also sensitized renal cancer Caki-1 cells and bladder cancer UM-UC-3 cells to TRAIL-induced apoptosis via down-regulation of XIAP. Co-treatment of chetomin and TRAIL did not enhance apoptosis in normal peripheral blood mononuclear cells (PBMC). Taken together, these findings suggest that TRAIL and chetomin synergistically induce apoptosis in human urogenital cancer cells through a mechanism that involves XIAP down-regulation by chetomin.

Related Articles

Journal Cover

February 2011
Volume 38 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Yano, K., Horinaka, M., Yoshida, T., Yasuda, T., Taniguchi, H., Goda, A.E. ... Sakai, T. (2011). Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells. International Journal of Oncology, 38, 365-374. https://doi.org/10.3892/ijo.2010.874
MLA
Yano, K., Horinaka, M., Yoshida, T., Yasuda, T., Taniguchi, H., Goda, A. E., Wakada, M., Yoshikawa, S., Nakamura, T., Kawauchi, A., Miki, T., Sakai, T."Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells". International Journal of Oncology 38.2 (2011): 365-374.
Chicago
Yano, K., Horinaka, M., Yoshida, T., Yasuda, T., Taniguchi, H., Goda, A. E., Wakada, M., Yoshikawa, S., Nakamura, T., Kawauchi, A., Miki, T., Sakai, T."Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells". International Journal of Oncology 38, no. 2 (2011): 365-374. https://doi.org/10.3892/ijo.2010.874